Literature DB >> 8120408

Characterization of unique human TCR V beta specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein.

R Watanabe-Ohnishi1, J Aelion, L LeGros, M A Tomai, E V Sokurenko, D Newton, J Takahara, S Irino, S Rashed, M Kotb.   

Abstract

The M protein of Streptococcus pyogenes plays a major role in the virulence of these bacteria. Members of the M protein superfamily are characterized by the presence of tandem segments of repeated amino acid sequences. The NH2-terminal end of the M proteins is a hypervariable region that harbors the type-specific epitopes of the molecule. Pepsin cleaves the molecule into a highly conserved carboxyl terminal half and a variable amino terminal portion referred to as pep M. In some individuals, infection with certain serotypes of group A streptococci is followed by autoimmune disorders such as rheumatic fever and acute glomerulonephritis. The serotypes of M protein that show a high degree of association with acute rheumatic fever are referred to as rheumatogenic serotypes. We have reported that one such serotype, type 5, is a superantigen to human T cells, specifically stimulating T cells bearing V beta 2, V beta 4, and V beta 8 elements. Here we extend our studies by examining other rheumatogenic serotypes for superantigenic properties. Studies with types 6, 18, 19, and 24 M proteins revealed that they are all superantigens to human T cells. The specificity to V beta 4 was shared by the rheumatogenic M proteins tested; however, each pep M serotype has its unique characteristic set of V beta specificity and these are distinct from those reported for the streptococcal pyrogenic exotoxins. The non-rheumatogenic serotype, pep M2, only stimulated V beta 2-bearing T cells. This study establishes that the structurally related M proteins represent a family of streptococcal superantigens analogous to the structurally related family of staphylococcal enterotoxin superantigens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Repertoire of transcribed peripheral blood T-cell receptor beta chain variable-region genes in acute rheumatic fever.

Authors:  W G Abbott; M A Skinner; L Voss; D Lennon; P L Tan; J D Fraser; I J Simpson; R Ameratunga; A Geursen
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Staphylococcal enterotoxin B primes cytokine secretion and lytic activity in response to native bacterial antigens.

Authors:  K M Mason; T D Dryden; N J Bigley; P S Fink
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

3.  Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.

Authors:  H Rikiishi; S Okamoto; S Sugawara; K Tamura; Z X Liu; K Kumagai
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients.

Authors:  M El-Demellawy; R El-Ridi; N I Guirguis; M Abdel Alim; A Kotby; M Kotb
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

6.  Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF.

Authors:  K H Schmidt; D Gerlach; L Wollweber; W Reichardt; K Mann; J H Ozegowski; B Fleischer
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

Review 7.  Superantigens and pseudosuperantigens of gram-positive cocci.

Authors:  B Fleischer; D Gerlach; A Fuhrmann; K H Schmidt
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

8.  Functional and Developmental Analysis of CD4(+)CD25(+) Regulatory T Cells under the Influence of Streptococcal M Protein in Rheumatic Heart Disease.

Authors:  Nidhal Abdul-Auhaimena; Zaman I L Al-Kaabi
Journal:  Iran J Med Sci       Date:  2011-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.